Key result
Prostaglandins, synthesized primarily from arachidonic acid, act as potent vasoactive agents mediating interactions between platelets and blood-vessel walls.
Provides an overview of arachidonic acid metabolites, prostaglandins, and their role in platelet and blood-vessel wall interactions.
PROSTAGLANDINS are potent vasoactive agents with a wide variety of other actions that depend on the species and organ tested and the prostaglandin used. They are synthesized from 20-carbon polyunsaturated fatty acids containing three, four or five double bonds. These fatty acids are present in the phospholipids of the cell membranes of all mammalian tissues. The main precursor of prostaglandins in man is eicosatetraenoic or arachidonic acid (four double bonds), which gives rise to the prostaglandins (PG's) containing two double bonds (PGE2, PGF2α, PGD2, prostacyclin and thromboxane A2). PGE2 and PGF . . .
No takes yet. Share an insight, caveat, or question.
Moncada et al. (1979) reported a review. Arachidonic acid metabolites was evaluated. Prostaglandins, synthesized primarily from arachidonic acid, act as potent vasoactive agents mediating interactions between platelets and blood-vessel walls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: